Recently, the limitations of the current blogging platform have become apparent when we started to consider the idea of adding some new features to the blog such as podcasts, video interviews, newsletters etc. A number of readers have also requested more extensive downloadable reports for purchase, so this is something we will be able to do in the near future through a more secure site.
« Lilly Cornered? Need to Buy Way Out? | Main | PhRMA Tries to Stave Off India's Compulsory Licenses Idea »
10/22/2010
Pharma Strategy Blog is moving!
| | |
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b013488658f64970c
Listed below are links to weblogs that reference Pharma Strategy Blog is moving!:
The comments to this entry are closed.
Recent Posts
- Put Myriad vs AMP to Bed
- Is that All I Get for My $100 Billion?
- Death of IPOs in Biotech -- Greatly Exaggerated?
- KV is BAAAAACK!
- FDA Oncology Chief Promises Use of Breakthrough Designation
- SAFC is Out and About
- J&J Coming to Grips
- How are R&D Chiefs Graded in Big Pharma?
- Better Late than Never for Japanese Pharma R&D Effort
- Marketing vs. R&D Spend Debate in BIG Pharma
Search
Archives
Categories
- AIDs
- Animal Health
- Antibody Drug Conjugates
- Brazil News
- Business Model
- Cell Engineering
- China news
- Clinical Results
- CNS Therapies
- Conservative Curmudgeon Palaver
- Current Events
- Development Funding & Investment
- Drug Development
- Economics
- Ethics
- Facility News
- FDA & EU Approvals
- Gene Therapy
- Generics & Biosimilars
- Government Policy
- Healthcare Reform
- India News
- Innovation
- Korea News
- Liberal Altruisim
- Manufacturing Challenges
- Market Data & Facts & Research
- Market Rumors
- Mergers & Acquisitions
- Oncology
- OpEx and Lean
- Orphan, Neglected & Rare Diseases
- Outsourcing
- Patents & Legal
- Personalized Medicine
- Process Development
- Product Licensing/Acquisition
- Product Recalls/Warning Letters
- Quality Management Systems
- R&D Changes & Trends
- Random Fun Stuff
- Raw Material Detectives
- Raw Material Testing
- Regenerative Medicine & Stem Cells
- Regulatory Affairs & Policy
- Reimbursement & 3rd Party Payers
- Risk Mitigation
- RNAi therapeutics
- Russia News
- Science & Technology
- Supply Chain Management
- Trade Policy
- Trade Shows, Seminars, & Webinars
- Translational Medicine
- Vaccines & Virus
- Venture Capital
- Virtual Biotech's
- Weblogs & Websites
- Whitepapers
Comments